Winning Health Technology Group Co.,Ltd. Class A

Winning Health Technology Group Co.,Ltd. Class A

SSZSE:300253
6.51
CNY
-0.12
(-1.81%)
-0.18EPS
15.36BMarket Cap
Apr 21Next Earn
Winning Health Technology Group Co.,Ltd. Class A
SZSE:300253
(Shenzhen Stock Exchange)

Recent

price

6.51

P/E

ratio

- -

div

yld

0.13%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.09
0.11
0.14
0.19
0.26
0.4
0.48
0.58
0.69
0.91
1.07
1.28
1.45
1.47
1.29
0.95
1.04
Revenue per Share
0.03
0.03
0.03
0.04
0.06
0.08
0.26
0.11
0.15
0.19
0.23
0.18
0.05
0.17
0.04
-0.17
-0.17
Basic EPS, GAAP
0.03
-0.01
0.01
0.02
0.01
-0.08
-0.1
-0.04
-0.02
0.02
0.1
0.04
-0.1
-0.06
0.05
0.15
- -
Free Cash Flow per Basic Share
0.01
- -
- -
- -
0.01
0.02
0.03
0.03
0.02
0.02
0.02
0.03
0.02
0.01
0.03
0.02
0.01
Dividend per Share
0.07
0.26
0.29
0.34
0.41
0.53
1.15
1.24
1.51
1.75
2.11
2.38
2.38
2.64
2.72
2.52
2.48
Book Value per Share
0.07
0.26
0.28
0.33
0.24
0.3
0.86
0.91
1.12
1.29
1.48
1.64
1.56
1.72
1.79
1.64
1.61
Tangible Book Value per Share
1,389
1,531
1,864
1,834
1,873
1,895
1,998
2,069
2,079
2,102
2,125
2,143
2,139
2,147
2,154
2,210
2,208
Basic Weighted Avg Shares
120
170
266
349
491
753
954
1,204
1,439
1,908
2,267
2,750
3,093
3,163
2,782
2,106
2,293
Sales/Revenue/Turnover
23.57
19.36
12.17
15.56
19.96
17.16
19.88
27.11
26.82
26.98
27.82
19.89
14.26
17.66
17.16
-2.71
-4.16
Operating Margin (%)
1
1
4
7
8
13
14
25
29
52
63
100
117
173
186
226
- -
Depreciation Expense
35
44
53
81
121
153
519
229
303
398
491
378
109
358
88
-374
-373
Net Income, GAAP
9.27
9.7
9.13
6.83
4.93
- -
9.94
10.34
0.87
4.13
7.44
5.21
61.71
6.79
42.42
- -
- -
Effective Tax Rate (%)
29.4
26.07
19.89
23.11
24.62
20.25
54.34
19.03
21.08
20.88
21.67
13.75
3.51
11.32
3.16
-17.75
-16.27
Profit Margin (%)
92
462
505
575
511
301
694
754
1,166
1,508
1,998
2,901
2,729
3,146
3,450
3,185
1,936
Working Capital
- -
- -
- -
- -
94
65
36
18
- -
1
6
920
975
1,019
1,066
1,113
17
LT Debt
95
478
532
630
792
1,048
2,407
2,659
3,332
3,916
4,714
5,173
5,127
5,681
5,934
5,596
5,449
Total Equity
29.93
10.56
6.6
8.35
11.04
- -
22.51
8.18
9.82
10.78
11.51
6.51
0.25
4.98
0.74
- -
- -
Return on Invested Capital (%)
40.09
14.23
8.99
13.12
15.24
- -
25.75
8.34
9.64
10.72
10.69
8.08
3.66
7.05
2.36
- -
- -
Return on Capital (%)
40.57
15.46
10.5
13.94
17.33
17.12
30.94
9.28
10.48
11.49
11.89
7.86
2.13
6.63
1.51
-6.48
-6.58
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
72
1,171
1,181
LT Borrowings
1,114
- -
- -
LT Finance Leases
13
12
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,216
2,201
2,201
Market Capitalization
18,588
14,815
15,365

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
4,725
4,607
4,522
Cash, Cash Equivalents & STI
1,611
1,593
1,518
Accounts Receivable, Net
1,069
999
981
Inventories
108
102
110
Total Current Liabilities
1,508
2,649
2,586
Payables & Accruals
- -
- -
- -
ST Debt
72
1,171
1,181
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.18%
3.68%
-5.7%
Free Cash Flow
-31.17%
-84.95%
229.38%
Net Income, GAAP
-19.43%
-93.12%
-525.38%
Sales/Revenue/Turnover
12.35%
-0.05%
-24.3%
Total Cash Common Dividend
13.75%
9.54%
-11.19%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
494
729
690
869
2,782
2025
345
494
- -
810
2,106
2026
397
597
488
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.06
-0.03
0.04
2025
- -
-0.06
- -
-0.06
-0.17
2026
0.01
-0.09
-0.03
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
- -
- -
0.03
2025
0.01
0.02
- -
- -
0.02
2026
0.01
- -
- -
- -
- -
Business
Winning Health Technology Group Co., Ltd. (300253.SZ) provides digital health services and healthcare information technology solutions to medical institutions and health organizations primarily in China. The company develops and offers core products including the WiNEX digital health platform; smart hospital solutions encompassing hospital information systems, electronic medical records, and electronic medical records application level 5 and above certifications; smart regional healthcare platforms for community, public health, and medical insurance regulation; Internet+ healthcare and telemedicine services; and WinCloud, a cloud-based delivery, operation, and maintenance management platform. Additional offerings cover IT solution design, planning, consulting, development, system integration, maintenance, and operation services tailored for smart hospitals and regional healthcare ecosystems. Founded in 1994 and headquartered in Shanghai, China, the company operates mainly across China with recent expansion into international markets, including the launch of the Macau Union Medical College Hospital project. It targets hospitals, regional health authorities, and health professionals, serving numerous tertiary hospitals and focusing on sectors such as medical informatization, commercial insurance, and intelligent healthcare ecosystems. In recent developments, the company increased its stake in subsidiary Huan Yao Weining Health Insurance Technology (Shanghai) Co., Ltd. through equity transfers and capital injections totaling approximately RMB 18.4 million in registered capital, raising its ownership from 42.5% to 78.6% as of early 2025 to enhance control and operational funding. Shanghai Kingstar Winning Software Technology Co., Ltd., a key subsidiary, introduced new strategic investors including Taiping (Shenzhen) Medical Health Industry Private Equity Fund and Taicang Kaihui Growth No. 2 Investment Fund via equity transfers and capital expansion to bolster commercial/medical insurance intelligent risk control and data businesses. In February 2025, it released upgraded products WingPt 2.8 and WineX Copilot 2.1, an AI-powered intelligent healthcare assistant integrated with DeepSeek, alongside ongoing R&D investments at 20.2% of 2024 revenue focused on WineX, AI applications, and over 600 Xinchuang (secure and controllable) certifications. The company reported 2024 revenue of RMB 2.78 billion, down 12% year-over-year, with Q1 2025 revenue at RMB 340 million, amid transitions to next-generation products like WinEx.